Applying Biologic Advances in Multiple Myeloma to Clinical Practice
In this video, Gareth J. Morgan, MD, discusses the new biologic advances in multiple myeloma and how they are currently being applied to clinical practice.
Gareth J. Morgan, MD, of the University of Arkansas for Medical Sciences in Little Rock, Arkansas, discusses the biologic advances in multiple myeloma, and how identified mutations and pathways can offer opportunities for patients to receive targeted therapies.
Dr. Morgan gave a presentation during an education session at the 2017 ASCO Meeting entitled, "Are We Integrating Biologic Advances in Multiple Myeloma Into Clinical Practice"?
Oncology Peer Review On-The-Go: Minority Treatment Disparities and Clinical Trial Enrollment
July 6th 2020The first episode of CancerNetwork's podcast Oncology Peer Review On-The-Go explores disparities in cancer care treatment among minorities and the significance of a representative sample in clinical trials.
